CEO Interview
Frelii, Inc. (OTC: FRLI) Developing personalized medicine using DNA big data & AI
Frelii, Inc. (OTC: FRLI), interview with CEO Ian Jenkins discussing the company’s personalized medicine technology which uses human DNA gene sequencing and artificial intelligence (AI) to […]